Form 4: Guardant Health Director Acquires Shares
Insider Transaction Report
Guardant Health Director Manuel Hidalgo Medina acquired 232 shares of common stock through the vesting of Restricted Stock Units on October 17, 2025.
Summary
- Manuel Hidalgo Medina, a Director of Guardant Health, Inc. (GH), reported a change in beneficial ownership.
- On October 17, 2025, Medina acquired 232 shares of Guardant Health Common Stock.
- This acquisition resulted from the vesting of Restricted Stock Units (RSUs) at a price of $0 per share.
- Following this transaction, Medina directly beneficially owns 1,315 shares of Common Stock.
- Medina also directly beneficially owns 7,657 derivative securities in the form of Restricted Stock Units.
- The RSUs were granted on July 17, 2024, with 25% vesting on the one-year anniversary (July 17, 2025), and the remaining 75% vesting monthly over the subsequent three-year period.
- The transaction was made pursuant to a Rule 10b5-1 plan.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction (RSU vesting) which is neutral in terms of immediate company performance or outlook. It reflects a pre-scheduled equity compensation event for a director.
Positives
- Director Manuel Hidalgo Medina increased his direct beneficial ownership of common stock, aligning his interests further with shareholders.
- The transaction was executed under a Rule 10b5-1 plan, indicating a pre-arranged trading strategy.
Future Outlook
NA
Industry Context
This is a routine insider transaction related to the vesting of equity compensation for a director. It does not provide specific insights into broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Indicates continued equity alignment of a director with shareholder interests.
- Employees: Reflects standard equity compensation practices for executives/directors.
Next Steps
- Remaining 75% of the Restricted Stock Units will continue to vest monthly over the three-year period following July 17, 2025.
Key Dates
| Date | Description |
|---|---|
| 2024-07-17 | Grant date of Restricted Stock Units. |
| 2025-07-17 | One-year anniversary of RSU grant, when 25% of the shares subject to the award vested. |
| 2025-10-17 | Transaction date for the acquisition of 232 common shares from RSU vesting. |
| 2025-10-20 | Date the Form 4 was signed. |
Keywords
Guardant Health, GH, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Director Stock Acquisition, Manuel Hidalgo Medina, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.